BookXingshun Qi, Yongping Yang, editors.
Summary: This book aims to provide an updated information on different types of major and emerging drugs for managing liver cirrhosis and its complications, including acute gastroesophageal variceal bleeding, ascites, hepatic encephalopathy, liver failure, acute kidney injury, and portal venous thrombosis. The chapters are organized by drug class, such as anti-HBV drugs, anti-HCV drugs, anticoagulants, and antibiotics, etc. The clinical efficacy, indication, and contra-indication of the various drug therapies are discussed using supportive reference material from authoritative sources and published clinical trials. It will be an invaluable reference for physicians who are treating patients with liver cirrhosis, especially those presenting with acute life-threatening complications.
Contents:
Anti-HBV drugs in liver cirrhosis
Anti-HCV drugs in liver cirrhosis
Anticoagulants in liver cirrhosis
Antibiotics in liver cirrhosis
Silymarin in liver cirrhosis
Ursodeoxycholic acid in liver cirrhosis
Emricasan in liver cirrhosis
Non-selective beta blockers in liver cirrhosis
Somatostatin and octreotide in liver cirrhosis
Terlipressin in liver cirrhosis
Diuretics in liver cirrhosis
Statins in liver cirrhosis
L-Ornithine L-Aspartate in liver cirrhosis
Lactulose in liver cirrhosis.